1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
RBC LIFE SCIENCE INC

RBC LIFE SCIENCE INC

OOTC:RBCL
0.00
USD
+0.00
(-0.14%)
-0.11EPS
619,642.80Market Cap
RBC LIFE SCIENCE INC
OTC:RBCL
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
TTM
USD
24.24
17.38
9.74
9.13
9.65
10.76
13.25
14.17
11.37
12.8
12.8
11.32
11.48
12.78
11.01
11.65
11.76
Revenue per Share
-0.8
-0.4
-0.06
0.27
0.3
0.22
0.83
0.75
-0.15
0.25
-0.03
-0.16
-0.23
-0.27
-0.34
-0.34
-0.11
Basic EPS, GAAP
-2.21
0.68
0.14
0.43
0.35
0.79
1.81
-0.68
-0.45
0.17
-0.1
-0.16
0.01
-0.76
-2
- -
0.08
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.69
2.29
1.88
2.15
2.44
2.78
3.71
4.28
4.21
4.44
4.44
4.28
4.07
3.81
3.56
3.22
3.12
Book Value per Share
0.89
0.52
0.67
0.97
1.28
1.58
2.51
3.23
3.14
3.38
3.39
3.23
3.03
2.79
2.58
2.24
2.14
Tangible Book Value per Share
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Basic Weighted Avg Shares
34
24
18
18
19
22
27
30
25
28
28
25
25
28
24
26
26
Sales/Revenue/Turnover
2.23
-0.65
0.62
3.56
4.49
4.45
10.72
9.38
-0.64
3.71
-0.25
-3.6
-2.45
-2.21
-10.31
-2.59
-0.53
Operating Margin (%)
1
1
1
1
1
1
- -
- -
- -
1
1
1
1
1
1
- -
- -
Depreciation Expense
-1
-1
- -
1
1
- -
2
2
- -
1
- -
- -
-1
-1
-1
-1
- -
Net Income, GAAP
- -
- -
- -
- -
4.32
38.92
37.06
39.63
- -
37.42
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-3.3
-2.29
-0.58
2.94
3.06
2.01
6.26
5.31
-1.34
1.98
-0.25
-1.44
-1.96
-2.13
-3.04
-2.93
-0.9
Profit Margin (%)
-1
-2
-1
- -
1
2
4
5
5
6
6
5
4
3
5
4
4
Working Capital
4
3
3
3
3
3
2
2
2
2
2
1
1
1
- -
- -
- -
LT Debt
4
3
4
4
5
6
8
9
9
10
10
10
9
8
8
7
7
Total Equity
- -
- -
- -
8.72
10.59
7.05
19.68
16.02
- -
5.67
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
7.2
7.53
5.21
18.25
16.02
- -
5.67
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-26.09
-16.06
-3.04
13.32
12.85
8.31
25.67
19.05
-3.6
5.84
-0.72
-3.73
-5.4
-6.91
-9.1
-10.08
-3.3
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'16
Mar'17
Jun'17
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
1
1
1

Working Capital

USD

•

in mil. unless spec.
Dec'16
Mar'17
Jun'17
Total Current Assets
8
8
9
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
1
2
1
Inventories
4
4
6
Total Current Liabilities
3
4
5
Payables & Accruals
3
3
4
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.29%
-6.26%
-9.51%
Free Cash Flow
-661.3%
-1,254.79%
-100.15%
Net Income, GAAP
27.28%
97.89%
1.95%
Sales/Revenue/Turnover
2.57%
-1.47%
5.78%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
5
6
5
7
24
2016
5
6
7
7
26
2017
6
6
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
-0.25
-0.11
0.15
-0.13
-0.34
2016
-0.18
-0.08
0.05
-0.12
-0.34
2017
0.02
-0.05
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
RBC Life Sciences, Inc. (OTC: RBCL) develops, manufactures, markets and distributes nutritional supplements and personal care products under the RBC Life brand, alongside advanced wound care and pain management solutions through its wholly owned subsidiary MPM Medical; its Nutritional Products segment offers herbs, vitamins, minerals, natural skin/hair/body care items, Stem-Kine dietary supplement, Microhydrin and Microhydrin Plus antioxidants, VitAloe blend, OliViva immune/cardiovascular beverage, Organic Spirulina, NeuroBright cognitive support, Colo-Vada Plus colon cleanser, HydraCel water enhancer, 24 Seven multivitamin/mineral, Immune 360 immune nourisher and Aloe Gelee soothing gel, marketed via independent distributors and licensing in North America, Southeast Asia and Australia; the Medical Products segment provides wound care for pressure/leg ulcers, cuts, burns and abrasions including cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials and Lidocaine hydrogel, plus radiation skin/tissue protection and pain/itch relief products sold under MPM Medical to U.S. hospitals, nursing homes, clinics and pharmacies through medical/surgical dealers and pharmaceutical distributors. Founded in 1988 and headquartered in Irving, Texas, the company targets wellness-seeking consumers and healthcare professionals across more than 30 countries with quality-assured products tested in-house and by independent labs. In January 2020, RBC Life Sciences received US Patent 8357422 for its NeuroBright supplement formulation supporting cognitive function, learning and memory based on an 18-month University of Texas at Dallas animal study demonstrating enhanced psychomotor abilities and longevity in test subjects.

Company News

Company News APIChatGPT

  • defenseworld.net

    Head-To-Head Analysis: Senestech (NASDAQ:SNES) vs. RBC Life Sciences (OTCMKTS:RBCL)

  • defenseworld.net

    Owens & Minor (NYSE:OMI) versus RBC Life Sciences (OTCMKTS:RBCL) Head to Head Survey